Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)

Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2) Publisher Pubmed

Salehi AM¹ ; Hajizadeh F² ; Barshidi A¹ ; Rashidi B¹ ; Ebrahimi F³ ; Bahmanpour S¹ ; Karpisheh V¹ ; Noukabadi FK⁴ ; Kiani FK¹ ; Hassannia H⁵ ; Atyabi F⁶ ; Kiaie SH^{1, 7} ; Kashanchi F⁸ ; Navashenaq JG⁹ Show All Authors

Salehi AM¹
Hajizadeh F²
Barshidi A¹
Rashidi B¹
Ebrahimi F³
Bahmanpour S¹
Karpisheh V¹
Noukabadi FK⁴
Kiani FK¹
Hassannia H⁵
Atyabi F⁶
Kiaie SH^{1, 7}
Kashanchi F⁸
Navashenaq JG⁹
Mohammadi H¹⁰
Bagherifar R⁷
Jafari R¹¹
Zolbanin NM^{12, 13, 14}
Jadidiniaragh F^{1, 15, 16}

Source: Pharmaceutical Research Published:2023

Abstract

The Editor-in-Chief has retracted this article because a number of images appear to overlap with each other, as well as with images from another article [1]. In particular:. © 2022 The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Related Docs

View other Related Docs

1. Retraction To: Investigating the Effects of Particle Size and Chemical Structure on Cytotoxicity and Bacteriostatic Potential of Nano Hydroxyapatite/Chitosan/Silica and Nano Hydroxyapatite/Chitosan/Silver; As Antibacterial Bone Substitutes (Journal of Nanoparticle Research, (2014), 16, 10, (2622), 10.1007/S11051-014-2622-9), Journal of Nanoparticle Research (2024)

2. Retraction Note: In Vitro Cytotoxicity and Anti-Cancer Drug Release Behavior of Methionine-Coated Magnetite Nanoparticles As Carriers (Medical Oncology, (2022), 39, 12, (252), 10.1007/S12032-022-01838-1), Medical Oncology (2025)

3. Retraction Note: The Role of Bismuth Nanoparticles in the Inhibition of Bacterial Infection (World Journal of Microbiology and Biotechnology, (2023), 39, 7, (190), 10.1007/S11274-023-03629-W), World Journal of Microbiology and Biotechnology (2023)

Experts (# of related papers)

View all Related Experts

Iraj Ragerdi Kashani (3)

Khosrow Najjari (2)

Style	Citing Format
MLA	Salehi AM, et al.. "Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)." Pharmaceutical Research, vol. 40, no. 2, 2023, pp. 615-616.
APA	Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidiniaragh F (2023). Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2). Pharmaceutical Research, 40(2), 615-616.
Chicago	Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, et al.. "Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)." Pharmaceutical Research 40, no. 2 (2023): 615-616.
Harvard	Salehi AM et al. (2023) 'Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)', Pharmaceutical Research, 40(2), pp. 615-616.
Vancouver	Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, et al.. Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2). Pharmaceutical Research. 2023;40(2):615-616.
BibTex	@article{ author = {Salehi AM and Hajizadeh F and Barshidi A and Rashidi B and Ebrahimi F and Bahmanpour S and Karpisheh V and Noukabadi FK and Kiani FK and Hassannia H and Atyabi F and Kiaie SH and Kashanchi F and Navashenaq JG and Mohammadi H and Bagherifar R and Jafari R and Zolbanin NM and Jadidiniaragh F}, title = {Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)}, journal = {Pharmaceutical Research}, volume = {40}, number = {2}, pages = {615-616}, year = {2023} }
RIS	TY - JOUR AU - Salehi AM AU - Hajizadeh F AU - Barshidi A AU - Rashidi B AU - Ebrahimi F AU - Bahmanpour S AU - Karpisheh V AU - Noukabadi FK AU - Kiani FK AU - Hassannia H AU - Atyabi F AU - Kiaie SH AU - Kashanchi F AU - Navashenaq JG AU - Mohammadi H AU - Bagherifar R AU - Jafari R AU - Zolbanin NM AU - Jadidiniaragh F TI - Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2) JO - Pharmaceutical Research VL - 40 IS - 2 SP - 615 EP - 616 PY - 2023 ER -

Style

Citing Format

MLA

Salehi AM, et al.. "Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)." Pharmaceutical Research, vol. 40, no. 2, 2023, pp. 615-616.

APA

Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidiniaragh F (2023). Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2). Pharmaceutical Research, 40(2), 615-616.

Chicago

Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, et al.. "Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)." Pharmaceutical Research 40, no. 2 (2023): 615-616.

Harvard

Salehi AM et al. (2023) 'Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)', Pharmaceutical Research, 40(2), pp. 615-616.

Vancouver

Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, et al.. Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2). Pharmaceutical Research. 2023;40(2):615-616.

BibTex

@article{ author = {Salehi AM and Hajizadeh F and Barshidi A and Rashidi B and Ebrahimi F and Bahmanpour S and Karpisheh V and Noukabadi FK and Kiani FK and Hassannia H and Atyabi F and Kiaie SH and Kashanchi F and Navashenaq JG and Mohammadi H and Bagherifar R and Jafari R and Zolbanin NM and Jadidiniaragh F}, title = {Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)}, journal = {Pharmaceutical Research}, volume = {40}, number = {2}, pages = {615-616}, year = {2023} }

RIS

TY - JOUR
AU - Salehi AM
AU - Hajizadeh F
AU - Barshidi A
AU - Rashidi B
AU - Ebrahimi F
AU - Bahmanpour S
AU - Karpisheh V
AU - Noukabadi FK
AU - Kiani FK
AU - Hassannia H
AU - Atyabi F
AU - Kiaie SH
AU - Kashanchi F
AU - Navashenaq JG
AU - Mohammadi H
AU - Bagherifar R
AU - Jafari R
AU - Zolbanin NM
AU - Jadidiniaragh F
TI - Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)
JO - Pharmaceutical Research
VL - 40
IS - 2
SP - 615
EP - 616
PY - 2023
ER -

Science Communicator Platform

Authors

Abstract